MedPath
HSA Approval

SODIUM BICARBONATE CAPSULE 500 mg

SIN05414P

SODIUM BICARBONATE CAPSULE 500 mg

SODIUM BICARBONATE CAPSULE 500 mg

February 18, 1991

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

B05CB04

sodium bicarbonate

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE LTD

Active Ingredients

SODIUM BICARBONATE

500 mg

Sodium bicarbonate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SODIUM BICARBONATE CAPSULE 500 mg - HSA Approval | MedPath